Subscribe
Close Sidebar
Politics
States
Economy
Society
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Legal
Movies
Sports
Subscribe
Sign In
Our Views
Politics
States
Economy
Society
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Legal
Movies
Sports
Magazine
Store
Pharmaceuticals
De-Risking Supply Chains: Big Pharma Turns To India To Reduce Reliance On China
Swarajya Staff
3d
News Headlines
Kerala Ayurveda Wins Rare US Patent For Herbal Formulation Uniquely Processed In Ancient Indian Tradition
Anand Parthasarathy
11mo
Science
Johnson & Johnson Announces Separation Of Businesses: Details You Need To Know
Bhaswati Guha Majumder
2yr
News Brief
All You Need To Know About Merck’s Covid Pill That Cuts Risk Of Death And Hospitalisation By 50 Per Cent
Bhaswati Guha Majumder
2yr
News Brief
Pakistan Lifts Ban On Import Of Lifesaving Drugs From India Over Fears Of Potentially Severe Shortages
Swarajya Staff
4yr
Insta
IIT Guwahati Collaborates With Hester Biosciences To Develop Vaccine Against Coronavirus
IANS
4yr
Insta
Indian Pharma Exports Surge 11 Percent in First Quarter; See 21 Percent Jump In July
Swarajya Staff
4yr
Insta
Modi Government 2.0 Looks To Introduce E-Pharmacy Project Within First 100 Days Of Power
Swarajya Staff
4yr
Insta
Government Ban Works: Unsafe FDC Medicine Sales Down By 56.4 Per Cent, Non-FDCs Up By 9.2 Per Cent
Swarajya Staff
5yr
Insta
Headache Gone For Piramal Enterprise: SC Exempts Saridon From Banned List In India
Swarajya Staff
5yr
Insta
Can’t Judge A Medicine By Its Name: Government To Regulate Brands Under Which Medicines Are Sold
Swarajya Staff
5yr
Insta
Gujarat Emerges As The Number One State In Manufacturing Quality Medicines In India
Swarajya Staff
5yr
Insta
Blocked At Doklam, What Will China Do Next? India Needs To Be Ready On Many Fronts
R Jagannathan
6yr
Politics
Rs 5.3 Lakh Crore Flowed Out Of India Illegally in 2007: Government Report
Swarajya Staff
7yr
Economy
Delhi HC Quashes Centre’s Ban On 344 FDC Medicines After Pharma Company Petitions
Swarajya Staff
7yr
Insta
Indian Pharma Sector Gets A Thumbs-Up From Moody’s
Swarajya Staff
7yr
Insta
Why Indian Pharma Sector Should Move From Generic To Innovation
Nilanjan Banik and Philip Stevens
8yr
Economy
Load More
Get Swarajya in your inbox.
Subscribe